• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The model for end-stage liver disease comes of age.

作者信息

Freeman Richard B

机构信息

Division of Transplant Surgery, Tufts-New England Medical Center, Box 40, 750 Washington Street, Boston, MA 02111, USA.

出版信息

Clin Liver Dis. 2007 May;11(2):249-63. doi: 10.1016/j.cld.2007.04.005.

DOI:10.1016/j.cld.2007.04.005
PMID:17606205
Abstract

The care of patients who have chronic liver disease has evolved considerably since the Model for End-stage Liver Disease (MELD) was first described 6 years ago. This article traces the progress in liver allocation and clinical liver disease research that includes the MELD score and highlights the management of areas in which MELD and the principles underlying MELD enhance the clinician's ability to understand better the patient who has chronic liver disease.

摘要

相似文献

1
The model for end-stage liver disease comes of age.
Clin Liver Dis. 2007 May;11(2):249-63. doi: 10.1016/j.cld.2007.04.005.
2
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.终末期肝病评分模型是人类免疫缺陷病毒1感染的终末期肝病患者最佳的预后因素:一项前瞻性队列研究。
Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.
3
Model for end-stage liver disease (MELD) exception guidelines.终末期肝病模型(MELD)例外指南
Liver Transpl. 2006 Dec;12(12 Suppl 3):S85-7. doi: 10.1002/lt.20961.
4
The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.终末期肝病模型评分的效用:肝移植候选资格的可靠指南,以及为特定患者同时进行临终关怀转诊的依据。
Liver Transpl. 2008 Aug;14(8):1100-6. doi: 10.1002/lt.21398.
5
[The value of MELD in the allocation of priority for liver transplantation candidates].[终末期肝病模型(MELD)在肝移植候选者优先排序分配中的价值]
Gastroenterol Hepatol. 2010 Apr;33(4):330-6. doi: 10.1016/j.gastrohep.2009.04.007. Epub 2009 Jul 23.
6
Model for end-stage liver disease (MELD) exception for polycystic liver disease.多囊肝病的终末期肝病模型(MELD)例外情况。
Liver Transpl. 2006 Dec;12(12 Suppl 3):S110-1. doi: 10.1002/lt.20974.
7
Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.在一个单一中心进行的198例肝移植手术中,终末期肝病模型(MELD)评分与尸体供体的器官分配情况。
Transplant Proc. 2008 Jul-Aug;40(6):1903-5. doi: 10.1016/j.transproceed.2008.05.016.
8
Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases.终末期肝病模型(MELD)对罕见代谢性肝病的例外情况。
Liver Transpl. 2006 Dec;12(12 Suppl 3):S124-7. doi: 10.1002/lt.20973.
9
Model for end-stage liver disease (MELD) exception for severe pruritus.终末期肝病模型(MELD)对严重瘙痒的例外情况。
Liver Transpl. 2006 Dec;12(12 Suppl 3):S119. doi: 10.1002/lt.20976.
10
Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems.非紧急肝移植中的分配优先级:拟议评分系统概述
Dig Liver Dis. 2009 Oct;41(10):700-6. doi: 10.1016/j.dld.2009.04.018. Epub 2009 Jun 6.

引用本文的文献

1
Waiting for a Liver Transplant in New Mexico; Understanding the State's Multi-layered Adversity.在新墨西哥州等待肝脏移植;了解该州的多重困境。
J Community Hosp Intern Med Perspect. 2024 Jul 2;14(4):1-5. doi: 10.55729/2000-9666.1365. eCollection 2024.
2
"Just" accuracy? Procedural fairness demands explainability in AI-based medical resource allocations.仅仅是“准确性”吗?程序公平性要求在基于人工智能的医疗资源分配中具备可解释性。
AI Soc. 2022 Dec 21:1-12. doi: 10.1007/s00146-022-01614-9.
3
Selection of patients with hepatocellular cancer: a difficult balancing between equity, utility, and benefit.
肝细胞癌患者的选择:在公平、实用性和益处之间艰难权衡。
Transl Gastroenterol Hepatol. 2017 Sep 21;2:75. doi: 10.21037/tgh.2017.09.04. eCollection 2017.
4
Model for end-stage liver disease score and MELD exceptions: 15 years later.终末期肝病模型评分与MELD例外情况:15年后
Hepatol Int. 2015 Jul;9(3):346-54. doi: 10.1007/s12072-015-9631-3. Epub 2015 May 28.
5
Transplant benefit for patients with hepatocellular carcinoma.肝肿瘤患者的移植获益。
World J Gastroenterol. 2013 Dec 28;19(48):9183-8. doi: 10.3748/wjg.v19.i48.9183.
6
Model for end-stage liver disease: end of the first decade.终末期肝病模型:第一个十年结束。
Clin Liver Dis. 2011 Nov;15(4):685-98. doi: 10.1016/j.cld.2011.08.009. Epub 2011 Oct 1.
7
Health-related quality of life and survival in liver transplant candidates.肝移植候选者的健康相关生活质量和生存情况。
Liver Transpl. 2010 Feb;16(2):238-45. doi: 10.1002/lt.21984.